Summit Ltd. is exploring to invest in a project to manufacture a blood testing device for retail market. The company has estimated annual fixed costs of $61,200, variable costs per unit of $84.29, a selling price of $199, and an initial cost of $402,000 for fixed assets. Depreciation is straight-line to zero over the project's 4-year life. The tax rate is 30 percent, and the discount rate is 12 percent. What is the financial break-even point (in units)